NCT04904146 Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
| NCT ID | NCT04904146 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lund University Hospital |
| Condition | Mycosis Fungoides |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2021-04-02 |
| Primary Completion | 2027-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2021-04-02 with a primary completion date of 2027-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A translational study for identification of prognostic and treatment-predictive biomarkers in Mycosis fungoides and Sézary syndrome.
Eligibility Criteria
Inclusion Criteria: * Age 18-100 years * Histologically confirmed (according to the World Health Organization (WHO)/EORTC classification) MF/SS stages I-IV * WHO performance status 0 -3 * Absence of psychiatric illness or condition which could interfere with the subjects' ability to understand the requirements of the study. * Written informed consent according to International Conference on Harmonization (ICH)/(Good Clinical Practice (GCP), and Swedish regulations * No minimum or maximum required routine laboratory data Exclusion Criteria: Not applicable. No exclusion criteria are specified.
Frequently Asked Questions
Who can join the NCT04904146 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Mycosis Fungoides. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04904146 currently recruiting?
Yes, NCT04904146 is actively recruiting participants. Visit ClinicalTrials.gov or contact Lund University Hospital to inquire about joining.
Where is the NCT04904146 trial being conducted?
This trial is being conducted at Lund, Sweden.
Who is sponsoring the NCT04904146 clinical trial?
NCT04904146 is sponsored by Lund University Hospital. The trial plans to enroll 120 participants.